News
Chatbots can get scary if you suspend your disbelief. But MJ Cocking didn’t — and wound up in a relationship that was ...
2h
Zacks Investment Research on MSNHims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to NoteHims & Hers Health, Inc. (HIMS) closed the most recent trading day at $47.60, moving -5.52% from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.14%. On ...
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...
One woman turns to Reddit after she's been paying to store her boyfriend’s broken car for months. But after watching him ...
Hims & Hers Health recurring revenue grew 111% YoY, boosted by personalization and chronic care. Forecasting $2.35B revenue ...
Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month ...
Explore more
Key Points Hims & Hers Health is entering the Canadian market.The company will offer a generic version of semaglutide in the ...
4don MSN
A woman shares how her dad expects her to house her cousin during a big move to the UK, but she refuses, sparking a family ...
When Dolly Parton was writing "9 To 5" she couldn't play her guitar because she was filming on set. So, her acrylic nails came in handy.
Hims & Hers (HIMS) stock in focus as the company faces a growing number of lawsuits following Novo Nordisk's (NVO) decision ...
The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in. | Novo ...
The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results